nodes	percent_of_prediction	percent_of_DWPC	metapath
Perphenazine—AOX1—Methotrexate—systemic scleroderma	0.128	0.226	CbGbCtD
Perphenazine—CYP2C8—Mometasone—systemic scleroderma	0.116	0.206	CbGbCtD
Perphenazine—CYP1A2—Pentoxifylline—systemic scleroderma	0.0608	0.108	CbGbCtD
Perphenazine—CYP1A2—Leflunomide—systemic scleroderma	0.058	0.103	CbGbCtD
Perphenazine—CYP2C9—Leflunomide—systemic scleroderma	0.0523	0.0927	CbGbCtD
Perphenazine—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0463	0.0821	CbGbCtD
Perphenazine—CYP2D6—Captopril—systemic scleroderma	0.0375	0.0665	CbGbCtD
Perphenazine—CYP2C19—Prednisone—systemic scleroderma	0.031	0.0551	CbGbCtD
Perphenazine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0188	0.0333	CbGbCtD
Perphenazine—CYP2C9—cardial valve—systemic scleroderma	0.0162	0.13	CbGeAlD
Perphenazine—CYP3A4—Prednisone—systemic scleroderma	0.015	0.0266	CbGbCtD
Perphenazine—HTR7—myenteric nerve plexus—systemic scleroderma	0.0123	0.0983	CbGeAlD
Perphenazine—HTR7—pulmonary artery—systemic scleroderma	0.00868	0.0696	CbGeAlD
Perphenazine—HTR2A—myenteric nerve plexus—systemic scleroderma	0.00764	0.0613	CbGeAlD
Perphenazine—HTR2A—pulmonary artery—systemic scleroderma	0.00541	0.0434	CbGeAlD
Perphenazine—CALM2—artery—systemic scleroderma	0.00331	0.0265	CbGeAlD
Perphenazine—CALM1—artery—systemic scleroderma	0.00329	0.0264	CbGeAlD
Perphenazine—HTR7—artery—systemic scleroderma	0.00322	0.0258	CbGeAlD
Perphenazine—CALM2—endothelium—systemic scleroderma	0.0028	0.0224	CbGeAlD
Perphenazine—CALM1—endothelium—systemic scleroderma	0.00278	0.0223	CbGeAlD
Perphenazine—HTR7—endothelium—systemic scleroderma	0.00272	0.0218	CbGeAlD
Perphenazine—CALM2—blood vessel—systemic scleroderma	0.00258	0.0207	CbGeAlD
Perphenazine—CALM1—blood vessel—systemic scleroderma	0.00257	0.0206	CbGeAlD
Perphenazine—HTR7—blood vessel—systemic scleroderma	0.00251	0.0201	CbGeAlD
Perphenazine—CYP2C18—digestive system—systemic scleroderma	0.00213	0.0171	CbGeAlD
Perphenazine—HTR2A—artery—systemic scleroderma	0.00201	0.0161	CbGeAlD
Perphenazine—HTR2A—endothelium—systemic scleroderma	0.0017	0.0136	CbGeAlD
Perphenazine—HTR2A—blood vessel—systemic scleroderma	0.00156	0.0125	CbGeAlD
Perphenazine—CALM3—smooth muscle tissue—systemic scleroderma	0.00154	0.0123	CbGeAlD
Perphenazine—AOX1—digestive system—systemic scleroderma	0.00135	0.0108	CbGeAlD
Perphenazine—CALM2—connective tissue—systemic scleroderma	0.00132	0.0106	CbGeAlD
Perphenazine—CALM1—connective tissue—systemic scleroderma	0.00132	0.0106	CbGeAlD
Perphenazine—HTR7—connective tissue—systemic scleroderma	0.00129	0.0103	CbGeAlD
Perphenazine—AOX1—tendon—systemic scleroderma	0.00128	0.0103	CbGeAlD
Perphenazine—CALM2—smooth muscle tissue—systemic scleroderma	0.00121	0.0097	CbGeAlD
Perphenazine—CALM1—smooth muscle tissue—systemic scleroderma	0.0012	0.00965	CbGeAlD
Perphenazine—CALM2—skin of body—systemic scleroderma	0.00119	0.00957	CbGeAlD
Perphenazine—CALM1—skin of body—systemic scleroderma	0.00119	0.00953	CbGeAlD
Perphenazine—HTR7—smooth muscle tissue—systemic scleroderma	0.00118	0.00943	CbGeAlD
Perphenazine—CALM3—tendon—systemic scleroderma	0.00116	0.00928	CbGeAlD
Perphenazine—AOX1—lung—systemic scleroderma	0.00113	0.00904	CbGeAlD
Perphenazine—CALM3—lung—systemic scleroderma	0.00102	0.00814	CbGeAlD
Perphenazine—HRH1—connective tissue—systemic scleroderma	0.00096	0.0077	CbGeAlD
Perphenazine—CALM2—digestive system—systemic scleroderma	0.000955	0.00766	CbGeAlD
Perphenazine—CALM1—digestive system—systemic scleroderma	0.00095	0.00762	CbGeAlD
Perphenazine—ADRA2A—connective tissue—systemic scleroderma	0.000943	0.00756	CbGeAlD
Perphenazine—HTR7—digestive system—systemic scleroderma	0.000928	0.00744	CbGeAlD
Perphenazine—CALM2—tendon—systemic scleroderma	0.000909	0.00729	CbGeAlD
Perphenazine—CYP2C19—digestive system—systemic scleroderma	0.000906	0.00727	CbGeAlD
Perphenazine—CALM1—tendon—systemic scleroderma	0.000904	0.00725	CbGeAlD
Perphenazine—CYP2B6—skin of body—systemic scleroderma	0.000887	0.00712	CbGeAlD
Perphenazine—HTR7—tendon—systemic scleroderma	0.000883	0.00708	CbGeAlD
Perphenazine—HRH1—smooth muscle tissue—systemic scleroderma	0.000878	0.00704	CbGeAlD
Perphenazine—HTR2A—connective tissue—systemic scleroderma	0.000801	0.00643	CbGeAlD
Perphenazine—CALM2—lung—systemic scleroderma	0.000797	0.00639	CbGeAlD
Perphenazine—CALM1—lung—systemic scleroderma	0.000794	0.00636	CbGeAlD
Perphenazine—HTR7—lung—systemic scleroderma	0.000775	0.00622	CbGeAlD
Perphenazine—CYP1A2—digestive system—systemic scleroderma	0.00074	0.00594	CbGeAlD
Perphenazine—HTR2A—smooth muscle tissue—systemic scleroderma	0.000733	0.00588	CbGeAlD
Perphenazine—DRD2—lung—systemic scleroderma	0.000733	0.00588	CbGeAlD
Perphenazine—CYP2B6—digestive system—systemic scleroderma	0.00071	0.00569	CbGeAlD
Perphenazine—CYP2C9—digestive system—systemic scleroderma	0.000703	0.00564	CbGeAlD
Perphenazine—HRH1—digestive system—systemic scleroderma	0.000693	0.00556	CbGeAlD
Perphenazine—HRH1—tendon—systemic scleroderma	0.00066	0.00529	CbGeAlD
Perphenazine—ADRA2A—tendon—systemic scleroderma	0.000648	0.0052	CbGeAlD
Perphenazine—Somnolence—Pentoxifylline—systemic scleroderma	0.000644	0.00229	CcSEcCtD
Perphenazine—Dry mouth—Mometasone—systemic scleroderma	0.000638	0.00227	CcSEcCtD
Perphenazine—Vision blurred—Captopril—systemic scleroderma	0.000634	0.00226	CcSEcCtD
Perphenazine—Orthostatic hypotension—Mycophenolate mofetil—systemic scleroderma	0.000633	0.00225	CcSEcCtD
Perphenazine—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.000632	0.00225	CcSEcCtD
Perphenazine—Decreased appetite—Pentoxifylline—systemic scleroderma	0.00063	0.00224	CcSEcCtD
Perphenazine—Oedema peripheral—Leflunomide—systemic scleroderma	0.000627	0.00223	CcSEcCtD
Perphenazine—Anaphylactic shock—Mometasone—systemic scleroderma	0.000625	0.00222	CcSEcCtD
Perphenazine—Photosensitivity reaction—Lisinopril—systemic scleroderma	0.000624	0.00222	CcSEcCtD
Perphenazine—Infection—Mometasone—systemic scleroderma	0.000621	0.00221	CcSEcCtD
Perphenazine—Constipation—Pentoxifylline—systemic scleroderma	0.00062	0.0022	CcSEcCtD
Perphenazine—Bradycardia—Mycophenolic acid—systemic scleroderma	0.000619	0.0022	CcSEcCtD
Perphenazine—CYP1A2—lung—systemic scleroderma	0.000618	0.00496	CbGeAlD
Perphenazine—Hyperglycaemia—Lisinopril—systemic scleroderma	0.000617	0.00219	CcSEcCtD
Perphenazine—Angioedema—Captopril—systemic scleroderma	0.000615	0.00219	CcSEcCtD
Perphenazine—Muscular weakness—Mycophenolate mofetil—systemic scleroderma	0.000611	0.00218	CcSEcCtD
Perphenazine—Hypoaesthesia—Mycophenolic acid—systemic scleroderma	0.000605	0.00215	CcSEcCtD
Perphenazine—Syncope—Captopril—systemic scleroderma	0.000603	0.00215	CcSEcCtD
Perphenazine—Dysphagia—Mycophenolate mofetil—systemic scleroderma	0.000599	0.00213	CcSEcCtD
Perphenazine—Asthma—Mycophenolate mofetil—systemic scleroderma	0.000599	0.00213	CcSEcCtD
Perphenazine—Oedema peripheral—Mycophenolic acid—systemic scleroderma	0.000599	0.00213	CcSEcCtD
Perphenazine—Anorexia—Mometasone—systemic scleroderma	0.000596	0.00212	CcSEcCtD
Perphenazine—Jaundice—Lisinopril—systemic scleroderma	0.000594	0.00211	CcSEcCtD
Perphenazine—CYP2B6—lung—systemic scleroderma	0.000593	0.00475	CbGeAlD
Perphenazine—Loss of consciousness—Captopril—systemic scleroderma	0.000591	0.0021	CcSEcCtD
Perphenazine—Cough—Captopril—systemic scleroderma	0.000587	0.00209	CcSEcCtD
Perphenazine—HTR2A—digestive system—systemic scleroderma	0.000579	0.00464	CbGeAlD
Perphenazine—HRH1—lung—systemic scleroderma	0.000579	0.00464	CbGeAlD
Perphenazine—Urticaria—Pentoxifylline—systemic scleroderma	0.000576	0.00205	CcSEcCtD
Perphenazine—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000573	0.00204	CcSEcCtD
Perphenazine—Dysarthria—Methotrexate—systemic scleroderma	0.000572	0.00203	CcSEcCtD
Perphenazine—Pancytopenia—Mycophenolate mofetil—systemic scleroderma	0.000569	0.00202	CcSEcCtD
Perphenazine—Agranulocytosis—Lisinopril—systemic scleroderma	0.000569	0.00202	CcSEcCtD
Perphenazine—ADRA2A—lung—systemic scleroderma	0.000569	0.00456	CbGeAlD
Perphenazine—Hyperkinesia—Prednisone—systemic scleroderma	0.000565	0.00201	CcSEcCtD
Perphenazine—Dry mouth—Captopril—systemic scleroderma	0.00056	0.00199	CcSEcCtD
Perphenazine—Dyspnoea—Mometasone—systemic scleroderma	0.000557	0.00198	CcSEcCtD
Perphenazine—Bradycardia—Lisinopril—systemic scleroderma	0.000557	0.00198	CcSEcCtD
Perphenazine—Confusional state—Captopril—systemic scleroderma	0.000554	0.00197	CcSEcCtD
Perphenazine—HTR2A—tendon—systemic scleroderma	0.000551	0.00442	CbGeAlD
Perphenazine—Anaphylactic shock—Captopril—systemic scleroderma	0.000549	0.00195	CcSEcCtD
Perphenazine—Decreased appetite—Mometasone—systemic scleroderma	0.000543	0.00193	CcSEcCtD
Perphenazine—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.00054	0.00192	CcSEcCtD
Perphenazine—Shock—Captopril—systemic scleroderma	0.00054	0.00192	CcSEcCtD
Perphenazine—Oedema peripheral—Lisinopril—systemic scleroderma	0.000539	0.00192	CcSEcCtD
Perphenazine—CYP3A4—digestive system—systemic scleroderma	0.000536	0.0043	CbGeAlD
Perphenazine—Tachycardia—Captopril—systemic scleroderma	0.000536	0.00191	CcSEcCtD
Perphenazine—Pain—Mometasone—systemic scleroderma	0.000535	0.0019	CcSEcCtD
Perphenazine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000534	0.0019	CcSEcCtD
Perphenazine—Muscle spasms—Leflunomide—systemic scleroderma	0.000533	0.0019	CcSEcCtD
Perphenazine—CYP2D6—digestive system—systemic scleroderma	0.000527	0.00423	CbGeAlD
Perphenazine—Leukopenia—Azathioprine—systemic scleroderma	0.000526	0.00187	CcSEcCtD
Perphenazine—Anorexia—Captopril—systemic scleroderma	0.000523	0.00186	CcSEcCtD
Perphenazine—Vision blurred—Leflunomide—systemic scleroderma	0.000523	0.00186	CcSEcCtD
Perphenazine—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.000521	0.00185	CcSEcCtD
Perphenazine—Hypotension—Captopril—systemic scleroderma	0.000513	0.00183	CcSEcCtD
Perphenazine—Pruritus—Pentoxifylline—systemic scleroderma	0.000513	0.00182	CcSEcCtD
Perphenazine—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.000509	0.00181	CcSEcCtD
Perphenazine—Angioedema—Leflunomide—systemic scleroderma	0.000507	0.0018	CcSEcCtD
Perphenazine—Vision blurred—Mycophenolic acid—systemic scleroderma	0.000499	0.00177	CcSEcCtD
Perphenazine—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.000498	0.00177	CcSEcCtD
Perphenazine—Insomnia—Captopril—systemic scleroderma	0.000497	0.00177	CcSEcCtD
Perphenazine—Leukopenia—Leflunomide—systemic scleroderma	0.000496	0.00177	CcSEcCtD
Perphenazine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000496	0.00176	CcSEcCtD
Perphenazine—Body temperature increased—Mometasone—systemic scleroderma	0.000494	0.00176	CcSEcCtD
Perphenazine—Dyspnoea—Captopril—systemic scleroderma	0.00049	0.00174	CcSEcCtD
Perphenazine—Urine output increased—Methotrexate—systemic scleroderma	0.000489	0.00174	CcSEcCtD
Perphenazine—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.000488	0.00174	CcSEcCtD
Perphenazine—Somnolence—Captopril—systemic scleroderma	0.000488	0.00174	CcSEcCtD
Perphenazine—Agitation—Mycophenolic acid—systemic scleroderma	0.000486	0.00173	CcSEcCtD
Perphenazine—Gynaecomastia—Methotrexate—systemic scleroderma	0.000484	0.00172	CcSEcCtD
Perphenazine—Cough—Leflunomide—systemic scleroderma	0.000484	0.00172	CcSEcCtD
Perphenazine—HTR2A—lung—systemic scleroderma	0.000483	0.00388	CbGeAlD
Perphenazine—Lethargy—Prednisone—systemic scleroderma	0.000479	0.00171	CcSEcCtD
Perphenazine—Dizziness—Pentoxifylline—systemic scleroderma	0.000479	0.0017	CcSEcCtD
Perphenazine—Hypertension—Leflunomide—systemic scleroderma	0.000479	0.0017	CcSEcCtD
Perphenazine—Decreased appetite—Captopril—systemic scleroderma	0.000477	0.0017	CcSEcCtD
Perphenazine—Hypoaesthesia—Mycophenolate mofetil—systemic scleroderma	0.000477	0.0017	CcSEcCtD
Perphenazine—Erythema—Lisinopril—systemic scleroderma	0.000476	0.0017	CcSEcCtD
Perphenazine—Infection—Azathioprine—systemic scleroderma	0.000476	0.00169	CcSEcCtD
Perphenazine—Syncope—Mycophenolic acid—systemic scleroderma	0.000474	0.00169	CcSEcCtD
Perphenazine—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000473	0.00168	CcSEcCtD
Perphenazine—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.000472	0.00168	CcSEcCtD
Perphenazine—Constipation—Captopril—systemic scleroderma	0.00047	0.00167	CcSEcCtD
Perphenazine—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.000465	0.00165	CcSEcCtD
Perphenazine—Dry mouth—Leflunomide—systemic scleroderma	0.000462	0.00164	CcSEcCtD
Perphenazine—Cough—Mycophenolic acid—systemic scleroderma	0.000462	0.00164	CcSEcCtD
Perphenazine—Psychotic disorder—Prednisone—systemic scleroderma	0.000459	0.00163	CcSEcCtD
Perphenazine—Convulsion—Mycophenolic acid—systemic scleroderma	0.000458	0.00163	CcSEcCtD
Perphenazine—Muscle spasms—Lisinopril—systemic scleroderma	0.000458	0.00163	CcSEcCtD
Perphenazine—Hypertension—Mycophenolic acid—systemic scleroderma	0.000457	0.00162	CcSEcCtD
Perphenazine—Headache—Pentoxifylline—systemic scleroderma	0.000454	0.00161	CcSEcCtD
Perphenazine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000453	0.00161	CcSEcCtD
Perphenazine—Infection—Leflunomide—systemic scleroderma	0.00045	0.0016	CcSEcCtD
Perphenazine—Vision blurred—Lisinopril—systemic scleroderma	0.000449	0.0016	CcSEcCtD
Perphenazine—Hypotension—Azathioprine—systemic scleroderma	0.000448	0.00159	CcSEcCtD
Perphenazine—Polyuria—Methotrexate—systemic scleroderma	0.000447	0.00159	CcSEcCtD
Perphenazine—Photosensitivity—Methotrexate—systemic scleroderma	0.000447	0.00159	CcSEcCtD
Perphenazine—Cardiac arrest—Prednisone—systemic scleroderma	0.000447	0.00159	CcSEcCtD
Perphenazine—Pruritus—Mometasone—systemic scleroderma	0.000442	0.00157	CcSEcCtD
Perphenazine—Tachycardia—Leflunomide—systemic scleroderma	0.000442	0.00157	CcSEcCtD
Perphenazine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00044	0.00157	CcSEcCtD
Perphenazine—Angioedema—Lisinopril—systemic scleroderma	0.000435	0.00155	CcSEcCtD
Perphenazine—Confusional state—Mycophenolic acid—systemic scleroderma	0.000435	0.00155	CcSEcCtD
Perphenazine—Body temperature increased—Captopril—systemic scleroderma	0.000434	0.00154	CcSEcCtD
Perphenazine—Anorexia—Leflunomide—systemic scleroderma	0.000431	0.00153	CcSEcCtD
Perphenazine—Infection—Mycophenolic acid—systemic scleroderma	0.000429	0.00153	CcSEcCtD
Perphenazine—Diarrhoea—Mometasone—systemic scleroderma	0.000428	0.00152	CcSEcCtD
Perphenazine—Syncope—Lisinopril—systemic scleroderma	0.000427	0.00152	CcSEcCtD
Perphenazine—Leukopenia—Lisinopril—systemic scleroderma	0.000426	0.00152	CcSEcCtD
Perphenazine—Shock—Mycophenolic acid—systemic scleroderma	0.000425	0.00151	CcSEcCtD
Perphenazine—Hypotension—Leflunomide—systemic scleroderma	0.000423	0.0015	CcSEcCtD
Perphenazine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000421	0.0015	CcSEcCtD
Perphenazine—Loss of consciousness—Lisinopril—systemic scleroderma	0.000419	0.00149	CcSEcCtD
Perphenazine—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.000416	0.00148	CcSEcCtD
Perphenazine—Cough—Lisinopril—systemic scleroderma	0.000416	0.00148	CcSEcCtD
Perphenazine—Muscular weakness—Prednisone—systemic scleroderma	0.000414	0.00147	CcSEcCtD
Perphenazine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000411	0.00146	CcSEcCtD
Perphenazine—Insomnia—Leflunomide—systemic scleroderma	0.000409	0.00146	CcSEcCtD
Perphenazine—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.000406	0.00144	CcSEcCtD
Perphenazine—Dyspnoea—Leflunomide—systemic scleroderma	0.000403	0.00144	CcSEcCtD
Perphenazine—Hypotension—Mycophenolic acid—systemic scleroderma	0.000403	0.00144	CcSEcCtD
Perphenazine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000401	0.00143	CcSEcCtD
Perphenazine—Lethargy—Methotrexate—systemic scleroderma	0.000401	0.00143	CcSEcCtD
Perphenazine—Dry mouth—Lisinopril—systemic scleroderma	0.000397	0.00141	CcSEcCtD
Perphenazine—Decreased appetite—Leflunomide—systemic scleroderma	0.000393	0.0014	CcSEcCtD
Perphenazine—Confusional state—Lisinopril—systemic scleroderma	0.000392	0.00139	CcSEcCtD
Perphenazine—Headache—Mometasone—systemic scleroderma	0.000392	0.00139	CcSEcCtD
Perphenazine—Insomnia—Mycophenolic acid—systemic scleroderma	0.00039	0.00139	CcSEcCtD
Perphenazine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000389	0.00138	CcSEcCtD
Perphenazine—Pruritus—Captopril—systemic scleroderma	0.000388	0.00138	CcSEcCtD
Perphenazine—Constipation—Leflunomide—systemic scleroderma	0.000387	0.00138	CcSEcCtD
Perphenazine—Pain—Leflunomide—systemic scleroderma	0.000387	0.00138	CcSEcCtD
Perphenazine—Infection—Lisinopril—systemic scleroderma	0.000386	0.00137	CcSEcCtD
Perphenazine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000385	0.00137	CcSEcCtD
Perphenazine—Somnolence—Mycophenolic acid—systemic scleroderma	0.000384	0.00137	CcSEcCtD
Perphenazine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000384	0.00136	CcSEcCtD
Perphenazine—Shock—Lisinopril—systemic scleroderma	0.000383	0.00136	CcSEcCtD
Perphenazine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000381	0.00136	CcSEcCtD
Perphenazine—Tachycardia—Lisinopril—systemic scleroderma	0.000379	0.00135	CcSEcCtD
Perphenazine—Body temperature increased—Azathioprine—systemic scleroderma	0.000379	0.00135	CcSEcCtD
Perphenazine—Diarrhoea—Captopril—systemic scleroderma	0.000376	0.00134	CcSEcCtD
Perphenazine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000375	0.00134	CcSEcCtD
Perphenazine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000374	0.00133	CcSEcCtD
Perphenazine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000374	0.00133	CcSEcCtD
Perphenazine—Anorexia—Lisinopril—systemic scleroderma	0.000371	0.00132	CcSEcCtD
Perphenazine—Ataxia—Methotrexate—systemic scleroderma	0.000369	0.00131	CcSEcCtD
Perphenazine—Pain—Mycophenolic acid—systemic scleroderma	0.000369	0.00131	CcSEcCtD
Perphenazine—Constipation—Mycophenolic acid—systemic scleroderma	0.000369	0.00131	CcSEcCtD
Perphenazine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000367	0.00131	CcSEcCtD
Perphenazine—Hyperglycaemia—Prednisone—systemic scleroderma	0.000366	0.0013	CcSEcCtD
Perphenazine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000364	0.0013	CcSEcCtD
Perphenazine—Hypotension—Lisinopril—systemic scleroderma	0.000363	0.00129	CcSEcCtD
Perphenazine—Dizziness—Captopril—systemic scleroderma	0.000363	0.00129	CcSEcCtD
Perphenazine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000362	0.00129	CcSEcCtD
Perphenazine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00036	0.00128	CcSEcCtD
Perphenazine—Urticaria—Leflunomide—systemic scleroderma	0.000359	0.00128	CcSEcCtD
Perphenazine—Body temperature increased—Leflunomide—systemic scleroderma	0.000358	0.00127	CcSEcCtD
Perphenazine—Hypersensitivity—Azathioprine—systemic scleroderma	0.000353	0.00126	CcSEcCtD
Perphenazine—Insomnia—Lisinopril—systemic scleroderma	0.000352	0.00125	CcSEcCtD
Perphenazine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000348	0.00124	CcSEcCtD
Perphenazine—Dyspnoea—Lisinopril—systemic scleroderma	0.000347	0.00123	CcSEcCtD
Perphenazine—Somnolence—Lisinopril—systemic scleroderma	0.000346	0.00123	CcSEcCtD
Perphenazine—Headache—Captopril—systemic scleroderma	0.000344	0.00122	CcSEcCtD
Perphenazine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000344	0.00122	CcSEcCtD
Perphenazine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000341	0.00121	CcSEcCtD
Perphenazine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000341	0.00121	CcSEcCtD
Perphenazine—Asthma—Methotrexate—systemic scleroderma	0.000339	0.00121	CcSEcCtD
Perphenazine—Infection—Mycophenolate mofetil—systemic scleroderma	0.000338	0.0012	CcSEcCtD
Perphenazine—Decreased appetite—Lisinopril—systemic scleroderma	0.000338	0.0012	CcSEcCtD
Perphenazine—Eosinophilia—Methotrexate—systemic scleroderma	0.000336	0.0012	CcSEcCtD
Perphenazine—Shock—Mycophenolate mofetil—systemic scleroderma	0.000335	0.00119	CcSEcCtD
Perphenazine—Hypersensitivity—Leflunomide—systemic scleroderma	0.000333	0.00119	CcSEcCtD
Perphenazine—Pain—Lisinopril—systemic scleroderma	0.000333	0.00118	CcSEcCtD
Perphenazine—Constipation—Lisinopril—systemic scleroderma	0.000333	0.00118	CcSEcCtD
Perphenazine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000333	0.00118	CcSEcCtD
Perphenazine—Bradycardia—Prednisone—systemic scleroderma	0.000331	0.00118	CcSEcCtD
Perphenazine—Diarrhoea—Azathioprine—systemic scleroderma	0.000328	0.00117	CcSEcCtD
Perphenazine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000325	0.00116	CcSEcCtD
Perphenazine—Pancytopenia—Methotrexate—systemic scleroderma	0.000322	0.00115	CcSEcCtD
Perphenazine—Pruritus—Leflunomide—systemic scleroderma	0.00032	0.00114	CcSEcCtD
Perphenazine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000318	0.00113	CcSEcCtD
Perphenazine—Dizziness—Azathioprine—systemic scleroderma	0.000317	0.00113	CcSEcCtD
Perphenazine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.00031	0.0011	CcSEcCtD
Perphenazine—Diarrhoea—Leflunomide—systemic scleroderma	0.00031	0.0011	CcSEcCtD
Perphenazine—Urticaria—Lisinopril—systemic scleroderma	0.000309	0.0011	CcSEcCtD
Perphenazine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000308	0.0011	CcSEcCtD
Perphenazine—Body temperature increased—Lisinopril—systemic scleroderma	0.000307	0.00109	CcSEcCtD
Perphenazine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000305	0.00109	CcSEcCtD
Perphenazine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000304	0.00108	CcSEcCtD
Perphenazine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000303	0.00108	CcSEcCtD
Perphenazine—Drowsiness—Methotrexate—systemic scleroderma	0.000303	0.00108	CcSEcCtD
Perphenazine—Headache—Azathioprine—systemic scleroderma	0.0003	0.00107	CcSEcCtD
Perphenazine—Dizziness—Leflunomide—systemic scleroderma	0.000299	0.00106	CcSEcCtD
Perphenazine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000296	0.00105	CcSEcCtD
Perphenazine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000295	0.00105	CcSEcCtD
Perphenazine—Pain—Mycophenolate mofetil—systemic scleroderma	0.000291	0.00104	CcSEcCtD
Perphenazine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000291	0.00104	CcSEcCtD
Perphenazine—Hypersensitivity—Lisinopril—systemic scleroderma	0.000286	0.00102	CcSEcCtD
Perphenazine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000285	0.00102	CcSEcCtD
Perphenazine—Headache—Leflunomide—systemic scleroderma	0.000283	0.00101	CcSEcCtD
Perphenazine—Erythema—Prednisone—systemic scleroderma	0.000283	0.00101	CcSEcCtD
Perphenazine—Agranulocytosis—Methotrexate—systemic scleroderma	0.000282	0.001	CcSEcCtD
Perphenazine—Pruritus—Lisinopril—systemic scleroderma	0.000275	0.000979	CcSEcCtD
Perphenazine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000271	0.000963	CcSEcCtD
Perphenazine—Headache—Mycophenolic acid—systemic scleroderma	0.00027	0.000962	CcSEcCtD
Perphenazine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000269	0.000958	CcSEcCtD
Perphenazine—Vision blurred—Prednisone—systemic scleroderma	0.000267	0.000949	CcSEcCtD
Perphenazine—Diarrhoea—Lisinopril—systemic scleroderma	0.000266	0.000947	CcSEcCtD
Perphenazine—Agitation—Prednisone—systemic scleroderma	0.00026	0.000925	CcSEcCtD
Perphenazine—Angioedema—Prednisone—systemic scleroderma	0.000259	0.00092	CcSEcCtD
Perphenazine—Dizziness—Lisinopril—systemic scleroderma	0.000257	0.000915	CcSEcCtD
Perphenazine—Syncope—Prednisone—systemic scleroderma	0.000254	0.000903	CcSEcCtD
Perphenazine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000251	0.000893	CcSEcCtD
Perphenazine—Loss of consciousness—Prednisone—systemic scleroderma	0.000249	0.000885	CcSEcCtD
Perphenazine—Convulsion—Prednisone—systemic scleroderma	0.000245	0.000872	CcSEcCtD
Perphenazine—Hypertension—Prednisone—systemic scleroderma	0.000244	0.000869	CcSEcCtD
Perphenazine—Headache—Lisinopril—systemic scleroderma	0.000244	0.000867	CcSEcCtD
Perphenazine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000241	0.000858	CcSEcCtD
Perphenazine—Erythema—Methotrexate—systemic scleroderma	0.000236	0.000841	CcSEcCtD
Perphenazine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000233	0.000829	CcSEcCtD
Perphenazine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000231	0.000822	CcSEcCtD
Perphenazine—Infection—Prednisone—systemic scleroderma	0.000229	0.000816	CcSEcCtD
Perphenazine—Shock—Prednisone—systemic scleroderma	0.000227	0.000808	CcSEcCtD
Perphenazine—Tachycardia—Prednisone—systemic scleroderma	0.000225	0.000802	CcSEcCtD
Perphenazine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000225	0.000802	CcSEcCtD
Perphenazine—Vision blurred—Methotrexate—systemic scleroderma	0.000223	0.000793	CcSEcCtD
Perphenazine—Anorexia—Prednisone—systemic scleroderma	0.00022	0.000783	CcSEcCtD
Perphenazine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000213	0.000759	CcSEcCtD
Perphenazine—Leukopenia—Methotrexate—systemic scleroderma	0.000212	0.000753	CcSEcCtD
Perphenazine—Insomnia—Prednisone—systemic scleroderma	0.000209	0.000743	CcSEcCtD
Perphenazine—Cough—Methotrexate—systemic scleroderma	0.000206	0.000734	CcSEcCtD
Perphenazine—Convulsion—Methotrexate—systemic scleroderma	0.000205	0.000729	CcSEcCtD
Perphenazine—Decreased appetite—Prednisone—systemic scleroderma	0.000201	0.000714	CcSEcCtD
Perphenazine—Constipation—Prednisone—systemic scleroderma	0.000197	0.000703	CcSEcCtD
Perphenazine—Confusional state—Methotrexate—systemic scleroderma	0.000195	0.000692	CcSEcCtD
Perphenazine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000193	0.000687	CcSEcCtD
Perphenazine—Infection—Methotrexate—systemic scleroderma	0.000192	0.000682	CcSEcCtD
Perphenazine—Anorexia—Methotrexate—systemic scleroderma	0.000184	0.000655	CcSEcCtD
Perphenazine—Urticaria—Prednisone—systemic scleroderma	0.000183	0.000653	CcSEcCtD
Perphenazine—Body temperature increased—Prednisone—systemic scleroderma	0.000183	0.00065	CcSEcCtD
Perphenazine—Hypotension—Methotrexate—systemic scleroderma	0.00018	0.000642	CcSEcCtD
Perphenazine—Insomnia—Methotrexate—systemic scleroderma	0.000175	0.000621	CcSEcCtD
Perphenazine—Dyspnoea—Methotrexate—systemic scleroderma	0.000172	0.000612	CcSEcCtD
Perphenazine—Somnolence—Methotrexate—systemic scleroderma	0.000172	0.00061	CcSEcCtD
Perphenazine—Hypersensitivity—Prednisone—systemic scleroderma	0.00017	0.000605	CcSEcCtD
Perphenazine—Decreased appetite—Methotrexate—systemic scleroderma	0.000168	0.000597	CcSEcCtD
Perphenazine—Pain—Methotrexate—systemic scleroderma	0.000165	0.000587	CcSEcCtD
Perphenazine—Pruritus—Prednisone—systemic scleroderma	0.000163	0.000581	CcSEcCtD
Perphenazine—Diarrhoea—Prednisone—systemic scleroderma	0.000158	0.000562	CcSEcCtD
Perphenazine—Urticaria—Methotrexate—systemic scleroderma	0.000153	0.000545	CcSEcCtD
Perphenazine—Dizziness—Prednisone—systemic scleroderma	0.000153	0.000543	CcSEcCtD
Perphenazine—Body temperature increased—Methotrexate—systemic scleroderma	0.000153	0.000543	CcSEcCtD
Perphenazine—Headache—Prednisone—systemic scleroderma	0.000145	0.000515	CcSEcCtD
Perphenazine—Hypersensitivity—Methotrexate—systemic scleroderma	0.000142	0.000506	CcSEcCtD
Perphenazine—Pruritus—Methotrexate—systemic scleroderma	0.000137	0.000486	CcSEcCtD
Perphenazine—Diarrhoea—Methotrexate—systemic scleroderma	0.000132	0.00047	CcSEcCtD
Perphenazine—Dizziness—Methotrexate—systemic scleroderma	0.000128	0.000454	CcSEcCtD
Perphenazine—Headache—Methotrexate—systemic scleroderma	0.000121	0.00043	CcSEcCtD
Perphenazine—HTR6—Signaling by GPCR—EDN1—systemic scleroderma	2.7e-05	0.00088	CbGpPWpGaD
Perphenazine—HTR7—Signaling by GPCR—EDN1—systemic scleroderma	2.7e-05	0.000879	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—RHOB—systemic scleroderma	2.69e-05	0.000876	CbGpPWpGaD
Perphenazine—HTR1A—GPCR ligand binding—CCL2—systemic scleroderma	2.66e-05	0.000868	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—CTLA4—systemic scleroderma	2.65e-05	0.000865	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—CTLA4—systemic scleroderma	2.65e-05	0.000865	CbGpPWpGaD
Perphenazine—HTR2C—GPCR ligand binding—CCL2—systemic scleroderma	2.65e-05	0.000863	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—SMAD7—systemic scleroderma	2.62e-05	0.000855	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—SMAD7—systemic scleroderma	2.58e-05	0.000842	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—SMAD7—systemic scleroderma	2.58e-05	0.00084	CbGpPWpGaD
Perphenazine—DRD1—GPCR downstream signaling—EDN1—systemic scleroderma	2.56e-05	0.000834	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—HSPG2—systemic scleroderma	2.54e-05	0.000828	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—HSPG2—systemic scleroderma	2.54e-05	0.000826	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	2.47e-05	0.000805	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—CSK—systemic scleroderma	2.45e-05	0.000798	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—SMAD7—systemic scleroderma	2.35e-05	0.000766	CbGpPWpGaD
Perphenazine—DRD2—GPCR ligand binding—CCL2—systemic scleroderma	2.34e-05	0.000762	CbGpPWpGaD
Perphenazine—CALM3—Immune System—CSK—systemic scleroderma	2.34e-05	0.000761	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—EDN1—systemic scleroderma	2.32e-05	0.000757	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—RHOB—systemic scleroderma	2.31e-05	0.000754	CbGpPWpGaD
Perphenazine—ADRA2A—Hemostasis—MMP1—systemic scleroderma	2.3e-05	0.00075	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—RHOB—systemic scleroderma	2.3e-05	0.00075	CbGpPWpGaD
Perphenazine—HTR2A—GPCR ligand binding—CCL2—systemic scleroderma	2.3e-05	0.00075	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IRF5—systemic scleroderma	2.3e-05	0.000749	CbGpPWpGaD
Perphenazine—HRH1—GPCR ligand binding—CCL2—systemic scleroderma	2.29e-05	0.000748	CbGpPWpGaD
Perphenazine—AOX1—Disease—NOS3—systemic scleroderma	2.28e-05	0.000743	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—HLA-DQB1—systemic scleroderma	2.26e-05	0.000736	CbGpPWpGaD
Perphenazine—CALM1—Immune System—CSK—systemic scleroderma	2.26e-05	0.000736	CbGpPWpGaD
Perphenazine—CALM2—Immune System—CSK—systemic scleroderma	2.26e-05	0.000736	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	2.25e-05	0.000734	CbGpPWpGaD
Perphenazine—CALM3—Disease—HSPG2—systemic scleroderma	2.23e-05	0.000728	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IRF5—systemic scleroderma	2.22e-05	0.000724	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IRF5—systemic scleroderma	2.22e-05	0.000724	CbGpPWpGaD
Perphenazine—HTR1A—GPCR downstream signaling—EDN1—systemic scleroderma	2.2e-05	0.000717	CbGpPWpGaD
Perphenazine—CALM3—Immune System—ITGAM—systemic scleroderma	2.2e-05	0.000716	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IRF8—systemic scleroderma	2.2e-05	0.000716	CbGpPWpGaD
Perphenazine—CALM3—Immune System—CD247—systemic scleroderma	2.2e-05	0.000716	CbGpPWpGaD
Perphenazine—HTR2C—GPCR downstream signaling—EDN1—systemic scleroderma	2.19e-05	0.000714	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—HLA-DQB1—systemic scleroderma	2.19e-05	0.000712	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—HLA-DQB1—systemic scleroderma	2.19e-05	0.000712	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—HSPG2—systemic scleroderma	2.18e-05	0.000711	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—HSPG2—systemic scleroderma	2.17e-05	0.000707	CbGpPWpGaD
Perphenazine—CALM1—Disease—HSPG2—systemic scleroderma	2.16e-05	0.000704	CbGpPWpGaD
Perphenazine—CALM2—Disease—HSPG2—systemic scleroderma	2.16e-05	0.000704	CbGpPWpGaD
Perphenazine—CALM3—Disease—CSK—systemic scleroderma	2.16e-05	0.000703	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—SMAD7—systemic scleroderma	2.14e-05	0.000699	CbGpPWpGaD
Perphenazine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	2.14e-05	0.000697	CbGpPWpGaD
Perphenazine—CALM3—Adaptive Immune System—CD40LG—systemic scleroderma	2.13e-05	0.000695	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IRF8—systemic scleroderma	2.12e-05	0.000692	CbGpPWpGaD
Perphenazine—CALM1—Immune System—ITGAM—systemic scleroderma	2.12e-05	0.000692	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IRF8—systemic scleroderma	2.12e-05	0.000692	CbGpPWpGaD
Perphenazine—CALM2—Immune System—ITGAM—systemic scleroderma	2.12e-05	0.000692	CbGpPWpGaD
Perphenazine—CALM2—Immune System—CD247—systemic scleroderma	2.12e-05	0.000692	CbGpPWpGaD
Perphenazine—CALM1—Immune System—CD247—systemic scleroderma	2.12e-05	0.000692	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CSK—systemic scleroderma	2.11e-05	0.000686	CbGpPWpGaD
Perphenazine—CALM3—Hemostasis—MMP1—systemic scleroderma	2.1e-05	0.000684	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CSK—systemic scleroderma	2.09e-05	0.000683	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR ligand binding—CCL2—systemic scleroderma	2.09e-05	0.000682	CbGpPWpGaD
Perphenazine—CALM1—Disease—CSK—systemic scleroderma	2.09e-05	0.00068	CbGpPWpGaD
Perphenazine—CALM2—Disease—CSK—systemic scleroderma	2.09e-05	0.00068	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—SMAD7—systemic scleroderma	2.07e-05	0.000676	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—SMAD7—systemic scleroderma	2.07e-05	0.000676	CbGpPWpGaD
Perphenazine—CALM1—Adaptive Immune System—CD40LG—systemic scleroderma	2.06e-05	0.000673	CbGpPWpGaD
Perphenazine—CALM2—Adaptive Immune System—CD40LG—systemic scleroderma	2.06e-05	0.000673	CbGpPWpGaD
Perphenazine—CALM3—Immune System—TNFAIP3—systemic scleroderma	2.06e-05	0.00067	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—HSPG2—systemic scleroderma	2.05e-05	0.000668	CbGpPWpGaD
Perphenazine—CALM3—Immune System—BLK—systemic scleroderma	2.03e-05	0.000662	CbGpPWpGaD
Perphenazine—CALM2—Hemostasis—MMP1—systemic scleroderma	2.03e-05	0.000662	CbGpPWpGaD
Perphenazine—CALM1—Hemostasis—MMP1—systemic scleroderma	2.03e-05	0.000662	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—RHOB—systemic scleroderma	2.03e-05	0.000662	CbGpPWpGaD
Perphenazine—CALM3—Disease—CD247—systemic scleroderma	2.03e-05	0.000661	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—EDN1—systemic scleroderma	2e-05	0.000651	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—RHOB—systemic scleroderma	2e-05	0.000651	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—RHOB—systemic scleroderma	1.99e-05	0.00065	CbGpPWpGaD
Perphenazine—CALM1—Immune System—TNFAIP3—systemic scleroderma	1.99e-05	0.000648	CbGpPWpGaD
Perphenazine—CALM2—Immune System—TNFAIP3—systemic scleroderma	1.99e-05	0.000648	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—EDN1—systemic scleroderma	1.99e-05	0.000648	CbGpPWpGaD
Perphenazine—CALM1—Immune System—BLK—systemic scleroderma	1.97e-05	0.000641	CbGpPWpGaD
Perphenazine—CALM2—Immune System—BLK—systemic scleroderma	1.97e-05	0.000641	CbGpPWpGaD
Perphenazine—CALM1—Disease—CD247—systemic scleroderma	1.96e-05	0.000639	CbGpPWpGaD
Perphenazine—CALM2—Disease—CD247—systemic scleroderma	1.96e-05	0.000639	CbGpPWpGaD
Perphenazine—CALM3—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	1.95e-05	0.000636	CbGpPWpGaD
Perphenazine—DRD2—GPCR downstream signaling—EDN1—systemic scleroderma	1.93e-05	0.00063	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—systemic scleroderma	1.92e-05	0.000627	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—HSPG2—systemic scleroderma	1.92e-05	0.000626	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—HSPG2—systemic scleroderma	1.91e-05	0.000624	CbGpPWpGaD
Perphenazine—AOX1—Metabolism—NOS3—systemic scleroderma	1.91e-05	0.000622	CbGpPWpGaD
Perphenazine—HTR2A—GPCR downstream signaling—EDN1—systemic scleroderma	1.9e-05	0.00062	CbGpPWpGaD
Perphenazine—HRH1—GPCR downstream signaling—EDN1—systemic scleroderma	1.9e-05	0.000618	CbGpPWpGaD
Perphenazine—CALM2—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	1.89e-05	0.000615	CbGpPWpGaD
Perphenazine—CALM1—Platelet activation, signaling and aggregation—TGFB1—systemic scleroderma	1.89e-05	0.000615	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—HSPG2—systemic scleroderma	1.88e-05	0.000614	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—HSPG2—systemic scleroderma	1.88e-05	0.000613	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—HSPG2—systemic scleroderma	1.87e-05	0.000609	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CSK—systemic scleroderma	1.85e-05	0.000603	CbGpPWpGaD
Perphenazine—HTR6—Signaling by GPCR—CCL2—systemic scleroderma	1.85e-05	0.000601	CbGpPWpGaD
Perphenazine—HTR7—Signaling by GPCR—CCL2—systemic scleroderma	1.84e-05	0.000601	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CSK—systemic scleroderma	1.82e-05	0.000593	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—RHOB—systemic scleroderma	1.82e-05	0.000592	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CSK—systemic scleroderma	1.81e-05	0.000592	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—HSPG2—systemic scleroderma	1.81e-05	0.00059	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—HSPG2—systemic scleroderma	1.81e-05	0.00059	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—EDN1—systemic scleroderma	1.75e-05	0.000572	CbGpPWpGaD
Perphenazine—ADRA2A—GPCR downstream signaling—EDN1—systemic scleroderma	1.73e-05	0.000564	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—EDN1—systemic scleroderma	1.73e-05	0.000563	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—EDN1—systemic scleroderma	1.72e-05	0.000561	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—HSPG2—systemic scleroderma	1.71e-05	0.000559	CbGpPWpGaD
Perphenazine—ADRA2A—Hemostasis—NOS3—systemic scleroderma	1.67e-05	0.000543	CbGpPWpGaD
Perphenazine—CALM3—Immune System—CTLA4—systemic scleroderma	1.66e-05	0.000542	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—RHOB—systemic scleroderma	1.66e-05	0.00054	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CSK—systemic scleroderma	1.65e-05	0.000539	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—HSPG2—systemic scleroderma	1.63e-05	0.00053	CbGpPWpGaD
Perphenazine—CALM2—Immune System—CTLA4—systemic scleroderma	1.61e-05	0.000525	CbGpPWpGaD
Perphenazine—CALM1—Immune System—CTLA4—systemic scleroderma	1.61e-05	0.000525	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—RHOB—systemic scleroderma	1.6e-05	0.000523	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—RHOB—systemic scleroderma	1.6e-05	0.000523	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—EDN1—systemic scleroderma	1.59e-05	0.00052	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—EDN1—systemic scleroderma	1.59e-05	0.000519	CbGpPWpGaD
Perphenazine—DRD1—Signaling by GPCR—CCL2—systemic scleroderma	1.59e-05	0.000518	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—EDN1—systemic scleroderma	1.57e-05	0.000512	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—HSPG2—systemic scleroderma	1.56e-05	0.00051	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—CTGF—systemic scleroderma	1.55e-05	0.000506	CbGpPWpGaD
Perphenazine—CALM3—Hemostasis—NOS3—systemic scleroderma	1.52e-05	0.000496	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—HSPG2—systemic scleroderma	1.51e-05	0.000493	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—HSPG2—systemic scleroderma	1.51e-05	0.000493	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CSK—systemic scleroderma	1.51e-05	0.000492	CbGpPWpGaD
Perphenazine—AOX1—Disease—TGFB1—systemic scleroderma	1.51e-05	0.000491	CbGpPWpGaD
Perphenazine—CALM2—Hemostasis—NOS3—systemic scleroderma	1.47e-05	0.00048	CbGpPWpGaD
Perphenazine—CALM1—Hemostasis—NOS3—systemic scleroderma	1.47e-05	0.00048	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CSK—systemic scleroderma	1.46e-05	0.000476	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CSK—systemic scleroderma	1.46e-05	0.000476	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—CTGF—systemic scleroderma	1.46e-05	0.000475	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—HSPG2—systemic scleroderma	1.45e-05	0.000473	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—EDN1—systemic scleroderma	1.43e-05	0.000467	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—CTGF—systemic scleroderma	1.42e-05	0.000462	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—EDN1—systemic scleroderma	1.39e-05	0.000452	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—EDN1—systemic scleroderma	1.39e-05	0.000452	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—EDN1—systemic scleroderma	1.37e-05	0.000447	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—CTGF—systemic scleroderma	1.37e-05	0.000447	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—CTGF—systemic scleroderma	1.37e-05	0.000447	CbGpPWpGaD
Perphenazine—CALM3—Immune System—HLA-DQB1—systemic scleroderma	1.37e-05	0.000447	CbGpPWpGaD
Perphenazine—HTR1A—Signaling by GPCR—CCL2—systemic scleroderma	1.37e-05	0.000445	CbGpPWpGaD
Perphenazine—HTR2C—Signaling by GPCR—CCL2—systemic scleroderma	1.36e-05	0.000443	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—HSPG2—systemic scleroderma	1.34e-05	0.000435	CbGpPWpGaD
Perphenazine—CALM2—Immune System—HLA-DQB1—systemic scleroderma	1.33e-05	0.000432	CbGpPWpGaD
Perphenazine—CALM1—Immune System—HLA-DQB1—systemic scleroderma	1.33e-05	0.000432	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—HSPG2—systemic scleroderma	1.32e-05	0.000432	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL1A—systemic scleroderma	1.3e-05	0.000424	CbGpPWpGaD
Perphenazine—CALM3—Immune System—CD40LG—systemic scleroderma	1.29e-05	0.000422	CbGpPWpGaD
Perphenazine—CYP2C18—Metabolism—NOS3—systemic scleroderma	1.29e-05	0.00042	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL1A—systemic scleroderma	1.26e-05	0.00041	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL1A—systemic scleroderma	1.26e-05	0.00041	CbGpPWpGaD
Perphenazine—CALM1—Immune System—CD40LG—systemic scleroderma	1.25e-05	0.000408	CbGpPWpGaD
Perphenazine—CALM2—Immune System—CD40LG—systemic scleroderma	1.25e-05	0.000408	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—CTGF—systemic scleroderma	1.23e-05	0.000402	CbGpPWpGaD
Perphenazine—DRD2—Signaling by GPCR—CCL2—systemic scleroderma	1.2e-05	0.000391	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—EDN1—systemic scleroderma	1.18e-05	0.000385	CbGpPWpGaD
Perphenazine—HTR2A—Signaling by GPCR—CCL2—systemic scleroderma	1.18e-05	0.000385	CbGpPWpGaD
Perphenazine—HRH1—Signaling by GPCR—CCL2—systemic scleroderma	1.18e-05	0.000384	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—EDN1—systemic scleroderma	1.17e-05	0.000383	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—HSPG2—systemic scleroderma	1.13e-05	0.000369	CbGpPWpGaD
Perphenazine—ADRA2A—Hemostasis—TGFB1—systemic scleroderma	1.1e-05	0.000359	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—CTGF—systemic scleroderma	1.1e-05	0.000359	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—CCL2—systemic scleroderma	1.09e-05	0.000355	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—CCL2—systemic scleroderma	1.09e-05	0.000355	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling by GPCR—CCL2—systemic scleroderma	1.07e-05	0.00035	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—EDN1—systemic scleroderma	1.04e-05	0.000338	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—EDN1—systemic scleroderma	1.02e-05	0.000332	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—EDN1—systemic scleroderma	1.02e-05	0.000332	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—CTGF—systemic scleroderma	1.01e-05	0.00033	CbGpPWpGaD
Perphenazine—CALM3—Hemostasis—TGFB1—systemic scleroderma	1.01e-05	0.000328	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—CTGF—systemic scleroderma	1e-05	0.000327	CbGpPWpGaD
Perphenazine—CALM3—Signaling by GPCR—CCL2—systemic scleroderma	9.79e-06	0.000319	CbGpPWpGaD
Perphenazine—CALM1—Hemostasis—TGFB1—systemic scleroderma	9.73e-06	0.000317	CbGpPWpGaD
Perphenazine—CALM2—Hemostasis—TGFB1—systemic scleroderma	9.73e-06	0.000317	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—NOS3—systemic scleroderma	9.71e-06	0.000317	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—NOS3—systemic scleroderma	9.7e-06	0.000316	CbGpPWpGaD
Perphenazine—CALM1—Signaling by GPCR—CCL2—systemic scleroderma	9.47e-06	0.000309	CbGpPWpGaD
Perphenazine—CALM2—Signaling by GPCR—CCL2—systemic scleroderma	9.47e-06	0.000309	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—CCL2—systemic scleroderma	9.38e-06	0.000306	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—EDN1—systemic scleroderma	9.28e-06	0.000302	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—HSPG2—systemic scleroderma	8.73e-06	0.000285	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—CTGF—systemic scleroderma	8.57e-06	0.000279	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—EDN1—systemic scleroderma	8.46e-06	0.000276	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—NOS3—systemic scleroderma	8.36e-06	0.000273	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—EDN1—systemic scleroderma	8.19e-06	0.000267	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—EDN1—systemic scleroderma	8.19e-06	0.000267	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—CCL2—systemic scleroderma	8.07e-06	0.000263	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—CCL2—systemic scleroderma	8.03e-06	0.000262	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—MMP9—systemic scleroderma	7.79e-06	0.000254	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—MMP9—systemic scleroderma	7.79e-06	0.000254	CbGpPWpGaD
Perphenazine—CALM3—Disease—NOS3—systemic scleroderma	7.36e-06	0.00024	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—NOS3—systemic scleroderma	7.19e-06	0.000234	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—NOS3—systemic scleroderma	7.15e-06	0.000233	CbGpPWpGaD
Perphenazine—CALM2—Disease—NOS3—systemic scleroderma	7.12e-06	0.000232	CbGpPWpGaD
Perphenazine—CALM1—Disease—NOS3—systemic scleroderma	7.12e-06	0.000232	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—CCL2—systemic scleroderma	7.08e-06	0.000231	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—CCL2—systemic scleroderma	6.97e-06	0.000227	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—CCL2—systemic scleroderma	6.96e-06	0.000227	CbGpPWpGaD
Perphenazine—CALM3—Immune System—IL1B—systemic scleroderma	6.79e-06	0.000221	CbGpPWpGaD
Perphenazine—ADRA2A—Metabolism—NOS3—systemic scleroderma	6.76e-06	0.00022	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—MMP9—systemic scleroderma	6.71e-06	0.000219	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—CTGF—systemic scleroderma	6.62e-06	0.000216	CbGpPWpGaD
Perphenazine—CALM2—Immune System—IL1B—systemic scleroderma	6.57e-06	0.000214	CbGpPWpGaD
Perphenazine—CALM1—Immune System—IL1B—systemic scleroderma	6.57e-06	0.000214	CbGpPWpGaD
Perphenazine—HTR6—Signaling Pathways—TGFB1—systemic scleroderma	6.42e-06	0.000209	CbGpPWpGaD
Perphenazine—HTR7—Signaling Pathways—TGFB1—systemic scleroderma	6.42e-06	0.000209	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—CCL2—systemic scleroderma	6.34e-06	0.000207	CbGpPWpGaD
Perphenazine—CYP2B6—Metabolism—NOS3—systemic scleroderma	6.34e-06	0.000207	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—NOS3—systemic scleroderma	6.31e-06	0.000206	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—NOS3—systemic scleroderma	6.21e-06	0.000203	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—NOS3—systemic scleroderma	6.2e-06	0.000202	CbGpPWpGaD
Perphenazine—CALM3—Metabolism—NOS3—systemic scleroderma	6.17e-06	0.000201	CbGpPWpGaD
Perphenazine—CALM1—Metabolism—NOS3—systemic scleroderma	5.97e-06	0.000194	CbGpPWpGaD
Perphenazine—CALM2—Metabolism—NOS3—systemic scleroderma	5.97e-06	0.000194	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—CCL2—systemic scleroderma	5.79e-06	0.000189	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—MMP9—systemic scleroderma	5.77e-06	0.000188	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—MMP9—systemic scleroderma	5.74e-06	0.000187	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—NOS3—systemic scleroderma	5.65e-06	0.000184	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—CCL2—systemic scleroderma	5.6e-06	0.000182	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—CCL2—systemic scleroderma	5.6e-06	0.000182	CbGpPWpGaD
Perphenazine—DRD1—Signaling Pathways—TGFB1—systemic scleroderma	5.53e-06	0.00018	CbGpPWpGaD
Perphenazine—CYP2C8—Metabolism—NOS3—systemic scleroderma	5.37e-06	0.000175	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—NOS3—systemic scleroderma	5.16e-06	0.000168	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—MMP9—systemic scleroderma	5.07e-06	0.000165	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—NOS3—systemic scleroderma	4.99e-06	0.000163	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—NOS3—systemic scleroderma	4.99e-06	0.000163	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—MMP9—systemic scleroderma	4.98e-06	0.000162	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—MMP9—systemic scleroderma	4.97e-06	0.000162	CbGpPWpGaD
Perphenazine—CALM3—Disease—TGFB1—systemic scleroderma	4.87e-06	0.000159	CbGpPWpGaD
Perphenazine—CYP2C19—Metabolism—NOS3—systemic scleroderma	4.79e-06	0.000156	CbGpPWpGaD
Perphenazine—HTR1A—Signaling Pathways—TGFB1—systemic scleroderma	4.76e-06	0.000155	CbGpPWpGaD
Perphenazine—HTR2C—Signaling Pathways—TGFB1—systemic scleroderma	4.73e-06	0.000154	CbGpPWpGaD
Perphenazine—CALM1—Disease—TGFB1—systemic scleroderma	4.71e-06	0.000154	CbGpPWpGaD
Perphenazine—CALM2—Disease—TGFB1—systemic scleroderma	4.71e-06	0.000154	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—MMP9—systemic scleroderma	4.53e-06	0.000148	CbGpPWpGaD
Perphenazine—CYP2D6—Metabolism—NOS3—systemic scleroderma	4.4e-06	0.000144	CbGpPWpGaD
Perphenazine—CYP2C9—Metabolism—NOS3—systemic scleroderma	4.37e-06	0.000142	CbGpPWpGaD
Perphenazine—DRD2—Signaling Pathways—TGFB1—systemic scleroderma	4.18e-06	0.000136	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—MMP9—systemic scleroderma	4.14e-06	0.000135	CbGpPWpGaD
Perphenazine—HTR2A—Signaling Pathways—TGFB1—systemic scleroderma	4.11e-06	0.000134	CbGpPWpGaD
Perphenazine—HRH1—Signaling Pathways—TGFB1—systemic scleroderma	4.1e-06	0.000134	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—MMP9—systemic scleroderma	4e-06	0.00013	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—MMP9—systemic scleroderma	4e-06	0.00013	CbGpPWpGaD
Perphenazine—ADRA2A—Signaling Pathways—TGFB1—systemic scleroderma	3.74e-06	0.000122	CbGpPWpGaD
Perphenazine—CYP1A2—Metabolism—NOS3—systemic scleroderma	3.73e-06	0.000122	CbGpPWpGaD
Perphenazine—CALM3—Signaling Pathways—TGFB1—systemic scleroderma	3.41e-06	0.000111	CbGpPWpGaD
Perphenazine—CALM2—Signaling Pathways—TGFB1—systemic scleroderma	3.3e-06	0.000108	CbGpPWpGaD
Perphenazine—CALM1—Signaling Pathways—TGFB1—systemic scleroderma	3.3e-06	0.000108	CbGpPWpGaD
Perphenazine—CYP3A4—Metabolism—NOS3—systemic scleroderma	2.88e-06	9.39e-05	CbGpPWpGaD
